Man shot while trying to hold up 3 federal agents in West Baltimore, police say

FDA approves reverse-anticoagulant drug Kcentra

When patients medicated for atrial fibrillation are brought to emergency departments with severe bleeding, reversing the effects of the anticoagulants they take can be difficult. The FDA has just approved a new product, Kcentra, for this purpose in some patients.
Lawrence K. Ho
Copyright © 2017, The Baltimore Sun, a Baltimore Sun Media Group publication | Place an Ad
72°